These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 33105719)

  • 21. Curcumin (Turmeric) and cancer.
    Unlu A; Nayir E; Dogukan Kalenderoglu M; Kirca O; Ozdogan M
    J BUON; 2016; 21(5):1050-1060. PubMed ID: 27837604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
    Bar-Sela G; Epelbaum R; Schaffer M
    Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
    Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin: therapeutical potential in ophthalmology.
    Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
    Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing plant-derived smart nano inhibitor in targeting mammalian target of rapamycin (mTOR) in breast cancer using Curcuma longa-derived compound curcumin.
    Alamri AH; Debnath S; Alqahtani T; Alqahtani A; Alshehri SA; Ghosh A
    Environ Sci Pollut Res Int; 2024 Jul; 31(34):46462-46469. PubMed ID: 36719580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
    Wang YT; Liu HS; Su CL
    Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
    Mbese Z; Khwaza V; Aderibigbe BA
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
    Moon DO
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management.
    Amaroli A; Panfoli I; Bozzo M; Ferrando S; Candiani S; Ravera S
    Cancers (Basel); 2024 Jul; 16(14):. PubMed ID: 39061221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin: a promising agent targeting cancer stem cells.
    Zang S; Liu T; Shi J; Qiao L
    Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
    Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
    Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin and Heme Oxygenase: Neuroprotection and Beyond.
    Mhillaj E; Tarozzi A; Pruccoli L; Cuomo V; Trabace L; Mancuso C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
    Azzini E; Peña-Corona SI; Hernández-Parra H; Chandran D; Saleena LAK; Sawikr Y; Peluso I; Dhumal S; Kumar M; Leyva-Gómez G; Martorell M; Sharifi-Rad J; Calina D
    Phytother Res; 2024 Jun; 38(6):3169-3189. PubMed ID: 38616356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
    Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
    J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor Activity of Curcumin in Glioblastoma.
    Walker BC; Mittal S
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Spicing up" of the immune system by curcumin.
    Jagetia GC; Aggarwal BB
    J Clin Immunol; 2007 Jan; 27(1):19-35. PubMed ID: 17211725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
    Soleimani V; Sahebkar A; Hosseinzadeh H
    Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on Curcuma as a functional food in the control of cancer and inflammation.
    Schaffer M; Schaffer PM; Bar-Sela G
    Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability.
    Nocito MC; De Luca A; Prestia F; Avena P; La Padula D; Zavaglia L; Sirianni R; Casaburi I; Puoci F; Chimento A; Pezzi V
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.